News Archive

2018

April

Media Release / Apr 20, 2018

New Novartis analyses at AAN show siponimod's efficacy on disability and cognition in secondary progressive MS patients

Read More
Media Release / Apr 19, 2018

Novartis appoints John Tsai Head of Global Drug Development and Chief Medical Officer

Read More
Media Release / Apr 19, 2018

Novartis delivered a strong first quarter and acted to become a more focused medicines company

Read More
Media Release / Apr 18, 2018

Sandoz signs agreement with Pear Therapeutics to develop and commercialize prescription digital therapeutics for patients with substance use disorder and opioid use disorders

Read More
Media Release / Apr 17, 2018

Novartis presents first-of-its-kind evidence at AAN reinforcing robust and consistent efficacy of AimovigTM* (erenumab) for migraine patients with multiple treatment failures

Read More
Media Release / Apr 17, 2018

Novartis renews commitment to malaria elimination, investing USD 100 million to research and develop next-generation antimalarials

Read More
Media Release / Apr 17, 2018

Novartis tender offer for AveXis commences

Read More
Media Release / Apr 16, 2018

Novartis announces new analysis demonstrating Entresto helped preserve kidney function in patients with chronic heart failure, especially those with diabetes

Read More
Media Release / Apr 09, 2018

Novartis enters agreement to acquire AveXis Inc. for USD 8.7 bn to transform care in SMA and expand position as a gene therapy and Neuroscience leader

Read More
Media Release / Apr 07, 2018

Sandoz outlines plans for next Healthcare Access Challenge (HACk), to support local digital innovation

Read More

Pages